NCT02974868 Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Status COMPLETED Phase PHASE2
NCT02974374 Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02969044 Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate Status COMPLETED Phase PHASE2
NCT02969018 Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02958865 Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02956967 Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia Status COMPLETED Phase N/A
NCT02955160 A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years Status COMPLETED Phase PHASE1
NCT02954653 A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02952586 Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Status TERMINATED Phase PHASE3
NCT02951156 Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) Status TERMINATED Phase PHASE3
NCT02947685 Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02947334 Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects Status WITHDRAWN Phase PHASE3
NCT02942355 Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02936154 Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects Status COMPLETED Phase PHASE1
NCT02935998 The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation Status UNKNOWN Phase PHASE4